The Clinical Significance of Antiphospholipid Antibodies

References

• Hughes G RV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341–4
   PubMed Web of Science ®Google Scholar
• Lockshln M D. Antiphospholipid syndrome. Rheum Dis Clin North Am 1994; 20: 45–59
   Google Scholar
• Khamashta M A, Hughes G RV. Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 1995; 7: 389–94
   PubMedGoogle Scholar
• Ravelli A, Martini A, Burgio G R. Antiphospholipid antibodies in paediatrics. Eur J Pediatr 1994; 153: 472–9
   PubMed Web of Science ®Google Scholar
• Ford S E, Kennedy L, Ford P M. Clinicopathologic correlations of antiphospholipid antibodies: an autopsy study. Arch Pathol Lab Med 1994; 118: 491–5
   Google Scholar
• Asherson R A. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508–12
   PubMed Web of Science ®Google Scholar
• Out H J, Kooijman C D, Bruinse H W, Derksen R HWM. Histopathological findings in placentae from patients with intra-uterine foetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991; 41: 179–86
   PubMed Web of Science ®Google Scholar
• Hunt B J, Khamashta M A. Management of the Hughes syndrome. Clin Exp Rheumatol 1996; 14: 115–7
   Google Scholar
• Galli M, Finazzi G, Barbui T. Thrombocytopenia in the antiphospholipid syndrome. Br J Haematol 1996; 93: 1–5
   PubMed Web of Science ®Google Scholar
• Moore J E, Mohr C F. Biologically false positive serologic test for syphilis. JAMA 1952; 150: 467–73
   PubMed Web of Science ®Google Scholar
• Triplett D A. Antiphospholipid antibodies: proposed mechanism of action. Am J Reprod Immunol 1992; 28: 211–5
   Google Scholar
• Harris E N, Gharavi A E, Boey M L, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–4
   PubMed Web of Science ®Google Scholar
• Harrls E N, Gharavi A E, Patel S P, Hughes G RV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215–22
   Google Scholar
• Roubey R AS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid' antibodies. Stood 1994; 84: 2854–67
   Google Scholar
• Triplett D A. Protean clinical presentation of antiphospho-lipid-protein antibodies (APA). Thromb Haemost 1995; 74: 329–37
   PubMedGoogle Scholar
• Dosekun A K, Pollak V E, Glas-Greenwalt P, et al. Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolytic effect. Arch Intern Med 1984; 144: 37–42
   Google Scholar
• Toubi E, Khamashta M A, Panarra A, Hughes G RV. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397–401
   PubMed Web of Science ®Google Scholar
• Rosove M H, Brewer P M. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Int Med 1992; 117: 303–8
   PubMed Web of Science ®Google Scholar
• Khamashta M A, Cuadrado M J, Mujic F, Taub N A, Hunt B J, Hughes G RV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993–7
   PubMed Web of Science ®Google Scholar
• Lockshln M D. Which patients with antiphospholipid antibody should be treated and how?. Rheum Dis Clin North Am 1993; 19: 235–47
   Google Scholar
• Harris E N, Spinnato J A. Should anticardiolipin tests be performed in otherwise healthy pregnant women?. Am J Obstet Gynecol 1991; 165: 1272–7
   PubMed Web of Science ®Google Scholar
• Abu-Shakra M, Gladman D D, Urowitz M B, Farewell V. Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations. Am J Med 1995; 99: 624–8
   PubMed Web of Science ®Google Scholar
• Ginsberg J S, Wells P S, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685–91
   PubMed Web of Science ®Google Scholar
• Silver R M, Porter F, Van Leeuween I, Jeng G, Scott J R, Branch D W. Anticardiolipin antibodies: clinical consequences of 'low titers'. Obstet Gynecol 1996; 87: 494–500
   PubMed Web of Science ®Google Scholar
• Caporali R, Ravelli A, Ramenghi B, Montecucco C, Martini A. Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis. Arch Dis Child 1992; 67: 1384–5
   PubMed Web of Science ®Google Scholar
• Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma cofactor. Lancet 1990; 335: 1544–7
   PubMed Web of Science ®Google Scholar
• McNeil H P, Simpson R J, Chesterman C N, Krilis S A. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: 2 glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120–4
   PubMed Web of Science ®Google Scholar
• Brighton T A, Hogg P J, Dal Y-P, Murray B H, Chong B H, Chesterman C N. Beta2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. Br J Haematol 1996; 93: 185–94
   Google Scholar
• McNally T, Purdy G, Mackie I J, Machin S J, Isenberg D A. The use of an anti-β2-glycoprotein-l assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995; 91: 471–3
   PubMedGoogle Scholar
• Arvieux J, Darnige L, Caron C, Reber G, Bensa J C, Colomb M G. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120–5
   PubMed Web of Science ®Google Scholar
• Bevers E M, Galli M, Barbui T, Comfurius P. Lupus anticoagulant IgQs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629–32
   PubMed Web of Science ®Google Scholar
• Oosting J D, Derksen R HWM, Bobbick I WG, Hckeng T M, Bouma B N, DeGroot P G. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S. An explanation for their pathogenic mechanism. Blood 1993; 81: 2618–25
   PubMed Web of Science ®Google Scholar
• Bajaj S P, Rapaport S I, Fierer D S, Herbst K D, Schwartz D B. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983; 61: 684–92
   PubMed Web of Science ®Google Scholar
• D'Angelo A, Delia Valle P, Crippa L, Pattarinl E, Grimaldi L ME, Vlgan Ò, D'Angelo S. Brief report: autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med 1993; 328: 1753–7
   Google Scholar
• Matsuura E, Igarashi Y, Yasuda T, Triplett D A, Koike T. Anticardiolipin antibodies recognize fi2 glycoprotein I structure altered to interact with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457–62
   PubMed Web of Science ®Google Scholar
• Ravelli A, Caporali R, Montecucco C, Martini A. The antiphospholipid syndrome in childhood. J Rheumatol 1996; 23: 1121–2
   Google Scholar
• Angellni L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994; 94: 500–3
   Google Scholar